Biotech news in September 2026

Who was in the news most?

1. Food and Drug Administration 9
2. Donald Trump 7
3. U.S. Department of Health and Human Services 4
4. Robert F. Kennedy Jr. 3
5. Pfizer 3
6. White House 2
7. Semaglutide 2
8. National Institutes of Health 2
9. Piramal Pharma Solutions 2
10. Johnson & Johnson 2
11. Ozempic 2
12. GLP-1 Receptor Agonists 2
13. Congress 2
14. Novo Nordisk 2
15. Wegovy 2

Counts are events (one per story, however many outlets carried it) on this desk in September 2026 that named each person, company or body. Source: GetYourBrief's record of the outlets' reports.

The week of September 14 to 20, 2026: 3 events

A quiet week on the desk, so its events are kept here in full rather than in a week brief.

1. 0119:45 UTC

   Trump directs OMB to draft order creating NIH grant approval board

   4 outlets · first: kval.com Funding

   Reported by kval.com, fox56.com, wcyb.com and nebraska.tv.

2. 0221:20 UTC

   Pfizer CEO says headwinds are easing

   2 outlets · first: fool.com Pharma

   Machine summary Pfizer CEO Albert Bourla said at a recent conference that the company has addressed tariff and drug-pricing challenges and that its coronavirus business no longer affects it as much, according to a report. Bourla also said new products generating $13 billion in annualized revenue and $7.2 billion in cost cuts should help mitigate patent cliffs, the report said.

   1. Bourla said Pfizer exceeded Wall Street's earnings-per-share estimates in all of the past 10 quarterly reporting periods and beat revenue expectations in nine of them, according to the report.

   Reported by fool.com and finance.yahoo.com.

   • Pfizer

3. 0318:30 UTC

   Pre-symptomatic Alzheimer's trials expand amid 139M dementia projection

   2 outlets · first: rnz.co.nz Clinical trial

   Machine summary A projected 139 million dementia cases by 2050.

   1. The World Alzheimer Report 2026 projects global dementia cases will surpass 139 million by 2050.
   2. Alzheimer's Disease International says Alzheimer's is starting to be considered a treatable and preventable condition, despite a cure still being far away.
   3. Disease-slowing drugs that target and remove amyloid plaque have entered the international market in recent years.
   4. Trials are underway, some involving New Zealand, treating people before symptoms to test whether cognitive impairment can be prevented.
   5. Dr Campbell Le Heron says the field is shifting from a nihilistic view, but improving diagnostic pathways and identifying at-risk people is essential.

   Reported by rnz.co.nz and nzherald.co.nz.

   • World Alzheimer Report 2026
   • Alzheimer's Disease International
   • Amyloid plaque

Which stories did the most outlets carry?

1. Sep 12 Rugby star Gareth Thomas joins HIV stigma campaign in Rio 6
2. Sep 6 2026 Expo: India Must Lead in New Molecules and Biotech, Says Goyal 4
3. Sep 9 Appeals court hears arguments on mifepristone prescribing rules 4
4. Sep 8 orlandosentinel.com: “FDA fills four senior roles, including top officials for drugs, vaccines and tobacco” 4
5. Sep 20 Trump directs OMB to draft order creating NIH grant approval board 4
6. Sep 22 GLP-1 drugmakers face lawsuits over alleged sudden vision loss risk 4
7. Sep 4 Clearmind Medicine to Acquire 51% of Charging Robotics Startup 2
8. Sep 5 Non-invasive endometriosis tests advance abroad; U.S. availability lags; 1 in 10 women 2
9. Sep 6 Novartis India's 5 therapy-area acquisition plan targets Tier 2/3 growth 2
10. Sep 6 Nuvation Bio safusidenib won FDA Fast Track in Aug. 2026; Cramer called stock speculation 2
11. Sep 8 My Green Lab expands ACT Ecolabel channel partner network 2
12. Sep 8 Protagonist Therapeutics announces $300 million share repurchase program 2
13. Sep 9 Study links semaglutide to fewer asthma attacks, COPD flare-ups 2
14. Sep 20 Pfizer CEO says headwinds are easing 2
15. Sep 20 Pre-symptomatic Alzheimer's trials expand amid 139M dementia projection 2

What kind of news was it?

1. Pharma 13
2. Fda approval 6
3. Acquisition 4
4. Clinical trial 4
5. Funding 4
6. Gene therapy 1

Categories come from the pipeline's classifier; how they are assigned.

Week by week

1. Aug 31The week of August 31 to September 6, 20265
2. Sep 7The week of September 7 to 13, 20267
3. Sep 14The week of September 14 to 20, 20263
4. Sep 21The week of September 21 to 27, 20266
5. Sep 28The week of September 28 to October 4, 20263